[同时测定卵巢癌患者血浆及腹水中的Ca 125和D-二聚体]
[Simultaneous determination of Ca 125 and D-dimer in plasma and ascites in ovarian cancer].
作者信息
Schröck R, Hafter R, Graeff H, Schmid L
出版信息
Onkologie. 1985 Oct;8(5):260-2. doi: 10.1159/000215670.
PMID:2999668
Abstract
In 37 patients with ovarian carcinoma stages Ic to IV the values of preoperatively determined tumour markers and the values of the follow-ups were examined in a trial to observe the course of the disease. The following sensitivity was recorded: Ca 125 92%, D-dimer 100%, TPA 76%, CEA 29%, CA 19-9 15%. Ca 125, D-dimer and TPA are unsuitable as follow-ups. They are also detectable in ascites.
摘要
在37例Ic至IV期卵巢癌患者中，对术前测定的肿瘤标志物值及随访值进行了检测，以观察疾病进程。记录到以下敏感度：癌抗原125（Ca 125）为92%，D - 二聚体为100%，组织多肽抗原（TPA）为76%，癌胚抗原（CEA）为29%，糖类抗原19 - 9（CA 19 - 9）为15%。Ca 125、D - 二聚体和TPA不适合用于随访。它们在腹水中也可检测到。
Zotero 插件